Qiao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qiao Wang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Qing Wang
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China
2 shared publications - Donghong Cui
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication Hwanhee Hong
Department of Biostatistics and Bioinformatics Duke University School of Medicine Durham North Carolina USA
1 shared publicationJialing Sheng
The First Minzheng Mental Health Center, No. 9999 Zhongchun Rd., Minhang, Shanghai, 201105, China
1 shared publication- Lizhao Du
Shanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, China
1 shared publication - Ru-Yuan Zhang
School of Psychological and Cognitive Sciences, Peking University, Beijing 100871, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 2 April 2026
- Published by Wiley in Statistics in Medicine
- Vol. 45 (8-9) , e70510
Bayesian Hierarchical Models With Calibrated Mixtures of g‐priors for Assessing Treatment Effect Moderation in Meta‐Analysis
Assessing treatment effect moderation is critical in biomedical science and many other fields, as it guides personalized interventions to improve individual health outcomes. Individual participant‐level data meta‐analysis (IPD‐MA) offers a robust framework for such assessments by leveraging data from multiple studies. However, its performance is often compromised by real‐world challenges, including but not limited to high between‐study variability or small magnitude of moderation effect. Traditional Bayesian shrinkage methods have gained popularity in addressing these challenges, but are less suitable in MA, as their priors do not discern heterogeneous studies. In this paper, we propose calibrated mixtures of g‐priors in IPD‐MA to enhance efficiency and reduce risks in estimating moderation effects, providing a novel series of priors tailored for multiple studies by incorporating a study‐level calibration parameter and a moderator‐level shrinkage. This design offers a flexible range of shrinkage levels, allowing practitioners to evaluate moderator importance from conservative and optimistic perspectives. Compared with existing Bayesian shrinkage methods, our simulation studies demonstrate that calibrated mixtures of g‐priors exhibit equivalent or superior performances in estimating moderation effects. The benefits of the proposed methods are particularly pronounced in scenarios with high between‐study variability, high model sparsity, weak moderation effects, and correlated design matrices. We illustrate their application in assessing moderators of two treatments for major depressive disorder, using IPD from four randomized controlled trials.
- 2 April 2026
- Published by Wiley in Statistics in Medicine
- Vol. 45 (8-9) , e70510
Open AccessBayesian Hierarchical Models With Calibrated Mixtures of g‐priors for Assessing Treatment Effect Moderation in Meta‐Analysis
Assessing treatment effect moderation is critical in biomedical science and many other fields, as it guides personalized interventions to improve individual health outcomes. Individual participant‐level data meta‐analysis (IPD‐MA) offers a robust framework for such assessments by leveraging data from multiple studies. However, its performance is often compromised by real‐world challenges, including but not limited to high between‐study variability or small magnitude of moderation effect. Traditional Bayesian shrinkage methods have gained popularity in addressing these challenges, but are less suitable in MA, as their priors do not discern heterogeneous studies. In this paper, we propose calibrated mixtures of g‐priors in IPD‐MA to enhance efficiency and reduce risks in estimating moderation effects, providing a novel series of priors tailored for multiple studies by incorporating a study‐level calibration parameter and a moderator‐level shrinkage. This design offers a flexible range of shrinkage levels, allowing practitioners to evaluate moderator importance from conservative and optimistic perspectives. Compared with existing Bayesian shrinkage methods, our simulation studies demonstrate that calibrated mixtures of g‐priors exhibit equivalent or superior performances in estimating moderation effects. The benefits of the proposed methods are particularly pronounced in scenarios with high between‐study variability, high model sparsity, weak moderation effects, and correlated design matrices. We illustrate their application in assessing moderators of two treatments for major depressive disorder, using IPD from four randomized controlled trials.
- Open Access
Network responses to meditation and baseline connectivity correlates of cognitive improvement in schizophrenia
Meditation-based rehabilitation may improve symptoms and cognition in schizophrenia, but how these responses relate to changes in brain-network interactions remains unclear. We conducted a secondary analysis of longitudinal clinical assessments and resting-state functional MRI at baseline, 3 and 8 months in a randomized trial of 64 male inpatients comparing meditation-based rehabilitation with general rehabilitation. Each analysis included all participants with the required measurements: 62 for clinical, 44 for three-visit connectivity and 43 for joint neural–clinical models. Symptom treatment effects increased between months 3 and 8, whereas cognitive benefit was clearest at 3 months. In the clinical cross-lagged panel model, early cognitive improvement was associated with cumulative symptom improvement at 8 months (β = 0.136; nominal P = 0.044); bootstrap intervals included zero for this association and the indirect treatment effect. Intrinsic network properties showed no treatment contrasts surviving multiplicity correction. Spectral dynamic causal modelling and parametric empirical Bayes identified eight treatment-associated connections shared across models with and without head-motion adjustment. Two early effects were consistent across five model specifications, sharing a supramarginal–frontal source with sensorimotor and bilateral middle-frontal targets. Adding baseline connectivity and early changes in these connections to clinical and motion covariates increased conditional in-sample R² most for 3-month cognitive improvement, by 0.147. Baseline connectivity supplied most of this increment (0.125); its two associations, modelled as common across treatment arms, retained their directions across all participant omissions. Early-change associations with clinical outcomes were imprecise. These findings distinguish treatment-responsive network interactions from the baseline connectivity that adds most information about cognitive improvement. They motivate a testable account in which initial sensory–attention coordination supports engagement with rehabilitation, while changing practice demands shape network responses.
Open AccessNetwork responses to meditation and baseline connectivity correlates of cognitive improvement in schizophrenia
Meditation-based rehabilitation may improve symptoms and cognition in schizophrenia, but how these responses relate to changes in brain-network interactions remains unclear. We conducted a secondary analysis of longitudinal clinical assessments and resting-state functional MRI at baseline, 3 and 8 months in a randomized trial of 64 male inpatients comparing meditation-based rehabilitation with general rehabilitation. Each analysis included all participants with the required measurements: 62 for clinical, 44 for three-visit connectivity and 43 for joint neural–clinical models. Symptom treatment effects increased between months 3 and 8, whereas cognitive benefit was clearest at 3 months. In the clinical cross-lagged panel model, early cognitive improvement was associated with cumulative symptom improvement at 8 months (β = 0.136; nominal P = 0.044); bootstrap intervals included zero for this association and the indirect treatment effect. Intrinsic network properties showed no treatment contrasts surviving multiplicity correction. Spectral dynamic causal modelling and parametric empirical Bayes identified eight treatment-associated connections shared across models with and without head-motion adjustment. Two early effects were consistent across five model specifications, sharing a supramarginal–frontal source with sensorimotor and bilateral middle-frontal targets. Adding baseline connectivity and early changes in these connections to clinical and motion covariates increased conditional in-sample R² most for 3-month cognitive improvement, by 0.147. Baseline connectivity supplied most of this increment (0.125); its two associations, modelled as common across treatment arms, retained their directions across all participant omissions. Early-change associations with clinical outcomes were imprecise. These findings distinguish treatment-responsive network interactions from the baseline connectivity that adds most information about cognitive improvement. They motivate a testable account in which initial sensory–attention coordination supports engagement with rehabilitation, while changing practice demands shape network responses.
- 25 September 2023
- Published by Taylor & Francis in Communications in Statistics - Theory and Methods
- Vol. 53 (20) , 7119-7143
A composite Bayesian approach for quantile curve fitting with non-crossing constraints
- 25 September 2023
- Published by Taylor & Francis in Communications in Statistics - Theory and Methods
- Vol. 53 (20) , 7119-7143
A composite Bayesian approach for quantile curve fitting with non-crossing constraints
- Open Access
- 2 March 2023
- Published by Oxford University Press (OUP) in Psychoradiology
- Vol. 3, kkad007
Claim causality with clarity
Causality and identification of the underlying mechanisms are the goals of scientific research. Many researchers devote their efforts to the formal formulation of causal inference to bridge the philosophical thinking and theoretical foundation for applied sciences, e.g. medical and health research, so that causal conclusions can be made. Nevertheless, the lure of fancy causal claims without clarity and rigorous sensitivity analysis can be misleading (Mehler & Kording, 2020). In this short review, we introduce the statistical basics for causal inference and the most commonly used methods to estimate causal effects, and provide suggestions for conducting open and reproducible causal analyses with clarity.
- 2 March 2023
- Published by Oxford University Press (OUP) in Psychoradiology
- Vol. 3, kkad007
Open AccessClaim causality with clarity
Causality and identification of the underlying mechanisms are the goals of scientific research. Many researchers devote their efforts to the formal formulation of causal inference to bridge the philosophical thinking and theoretical foundation for applied sciences, e.g. medical and health research, so that causal conclusions can be made. Nevertheless, the lure of fancy causal claims without clarity and rigorous sensitivity analysis can be misleading (Mehler & Kording, 2020). In this short review, we introduce the statistical basics for causal inference and the most commonly used methods to estimate causal effects, and provide suggestions for conducting open and reproducible causal analyses with clarity.